JNJ-6892

N/A

Report date: 2025/01/26 18:06:21

Base Information

Drug NameJNJ-6892
Drug Alias NameOX40 costimulator (Janssen/Bioceros)OX40 costimulator mAb (Janssen/Bioceros)JNJ-6892
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 4 agonists
TargetsTumor necrosis factor receptor superfamily member 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBioceros
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Pharmaceuticals Inc
Inactive CompaniesBioceros
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A